产品
编 号:F131060
分子式:C30H40Cl2N2O2
分子量:531.56
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
1mg
询价
询价
5mg
询价
询价
10mg
询价
询价
结构图
联系客服
产品详情
生物活性:
Elacestrant (RAD1901) dihydrochloride is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant dihydrochloride also can inhibit growth of ER+ breast cancer cell lines in vitro and in vivo.

体内研究:
Elacestrant dihydrochloride (0.3-120 mg/kg; p.o.; single daily for 40 days) 在大鼠中以剂量依赖的方式拮抗 E2 介导的子宫刺激。Elacestrant dihydrochloride (30, 60 mg/kg; p.o.; single daily for 4 weeks) 在小鼠体内完全抑制肿瘤生长。Elacestrant dihydrochloride 在停药后,还能持续四周抑制肿瘤生长.Animal Model:MCF7 cell line xenograft model of mice.
Dosage:30, 60 mg/kg
Administration:Oral administration; single daily for 4 weeks.
Result:Inhibited growth of tumor.

体外研究:
Elacestrant dihydrochloride (RAD1901; 0.5 nM-10 μM; 48 h) 在 MCF-7 细胞中,以浓度依赖的方式抑制 ERα 的表达 (EC50 = 0.6 nM)。Elacestrant dihydrochloride (0-1 μM; 48 h) 以浓度依赖的方式对雌二醇 (E2) 刺激的 ER 阳性 MCF-7 细胞显示出抗增殖活性 (EC50 = 4 pM) 。Elacestrant dihydrochloride (0-1 μM; 24 or 48 h) 在 MCF7, T47D 和 HCC1428 细胞中,抑制雌激素受体蛋白的表达。Elacestrant dihydrochloride (0.01, 0.1, 1.0 μM) 能降低 MCF7 和 T47D 细胞系中孕酮受体 (PGR、PR; 一种 ER 靶基因) 的表达。
产品资料